Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Change in Accured Expenses (2016 - 2025)

Traws Pharma (TRAW) has disclosed Change in Accured Expenses for 14 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 475.58% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $2.4 million, up 145.45%, while the annual FY2025 figure was $2.4 million, 145.45% up from the prior year.
  • Change in Accured Expenses hit $2.7 million in Q4 2025 for Traws Pharma, up from $189000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.7 million in Q4 2025 and bottomed at -$4.1 million in Q2 2024.
  • Average Change in Accured Expenses over 5 years is -$221700.0, with a median of $2500.0 recorded in 2023.
  • Year-over-year, Change in Accured Expenses skyrocketed 589.15% in 2022 and then plummeted 1144.93% in 2024.
  • Traws Pharma's Change in Accured Expenses stood at $383000.0 in 2021, then skyrocketed by 59.27% to $610000.0 in 2022, then crashed by 87.7% to $75000.0 in 2023, then soared by 528.0% to $471000.0 in 2024, then skyrocketed by 475.58% to $2.7 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $2.7 million, $189000.0, and $74000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.